Lamark Biotech - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2018, Lamark Biotech operates in Health Tech offering innovative molecular medicines to support sustainable and affordable healthcare systems globally. The company focuses on developing the...
Funding stage:
Pre-Series A
Last funding:
30/06/2025
Total funding:
$760.22K+
Revenue:
Investors
Employee count:
13
Last 90d
13
Last 90d
Web traffic:
1.08K
1.08K
Last 30d
Last 30d
Lamark Biotech: Funding Highlights
Funding highlights of Lamark Biotech and a snapshot of its key metrics.
Total Funding$760.22K+
Current StageGrowth Stage
Total Round(s)1
Funding Rounds
FAQs on Funding of Lamark Biotech
Health Tech Funded Lamark Biotech has raised a total funding of $760.22K as of 01 July 2025 across 1 rounds. Find the details around funding rounds, participating investors, and other insights of Lamark Biotech here...
Lamark Biotech has raised a total of $760.22K across 1 funding rounds and the last round was raised on 01 July 2025.
Lamark Biotech's key investors include IAN Fund, BioAngels, Nita Roy and 2 others.
Lamark Biotech's latest funding round was $760.22K in Growth Stage, raised on 01 July 2025.
Lamark Biotech is at the Growth stage. Its most recent round was raised on 01 July 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links